Kenji Murata
Princess Margaret Cancer Centre, University Health Network, Toronto, Canada
Competing interests
Kenji Murata, The University Health Network has filed patent application related to this study on which Kenji Murata is named as an inventor (US16/095,913, US62/813,639, US62/813,642, US62/813,644, US62/813,645, US62/813,647, US62/813,650, US62/813,651, and US62/823,487)..
Munehide Nakatsugawa
Princess Margaret Cancer Centre, University Health Network, Toronto, Canada
Competing interests
Munehide Nakatsugawa, The University Health Network has filed patent application related to this study on which Munehide Nakatsugawa is named as an inventor (US16/095,913)..
Muhammed A Rahman
Princess Margaret Cancer Centre, University Health Network, Toronto, Canada
Competing interests
Muhammed A Rahman, The University Health Network has filed patent application related to this study on which Muhammed A. Rahman is named as an inventor (US16/095,913)..
Linh T Nguyen
Princess Margaret Cancer Centre, University Health Network, Toronto, Canada
Competing interests
No competing interests declared.
Douglas G Millar
Princess Margaret Cancer Centre, University Health Network, Toronto, Canada
Competing interests
No competing interests declared.
David Thomas Mulder
Clinical Cancer Genomics, University Health Network, Toronto, Canada
Competing interests
No competing interests declared.
Kenji Sugata
Princess Margaret Cancer Centre, University Health Network, Toronto, Canada
Competing interests
No competing interests declared.
Hiroshi Saijo
Princess Margaret Cancer Centre, University Health Network, Toronto, Canada
Competing interests
No competing interests declared.
Yukiko Matsunaga
Princess Margaret Cancer Centre, University Health Network, Toronto, Canada
Competing interests
No competing interests declared.
Yuki Kagoya
Princess Margaret Cancer Centre, University Health Network, Toronto, Canada
Competing interests
No competing interests declared.
Tingxi Guo
Princess Margaret Cancer Centre, University Health Network, Toronto, Canada
Competing interests
No competing interests declared.
Mark Anczurowski
Department of Immunology, University of Toronto, Toronto, Canada
Competing interests
No competing interests declared.
Chung-Hsi Wang
Princess Margaret Cancer Centre, University Health Network, Toronto, Canada
Competing interests
No competing interests declared.
Brian D Burt
Princess Margaret Cancer Centre, University Health Network, Toronto, Canada
Competing interests
No competing interests declared.
Dalam Ly
Princess Margaret Cancer Centre, University Health Network, Toronto, Canada
Competing interests
No competing interests declared.
Kayoko Saso
Princess Margaret Cancer Centre, University Health Network, Toronto, Canada
Competing interests
Kayoko Saso, The University Health Network has filed patent application related to this study on which Kayoko Saso is named as an inventor (US62/813,639, US62/813,642, US62/813,644, US62/813,645, US62/813,647, US62/813,650, US62/813,651, and US62/823,487)..
Alexandra Easson
Surgical Oncology, University Health Network, Toronto, Canada
Competing interests
No competing interests declared.
David P Goldstein
Surgical Oncology, University Health Network, Toronto, Canada
Competing interests
No competing interests declared.
Michael Reedijk
Surgical Oncology, University Health Network, Toronto, Canada
Competing interests
No competing interests declared.
Danny A Ghazarian
Laboratory Medicine and Pathobiology, University Health Network, Toronto, Canada
Competing interests
No competing interests declared.
Trevor J Pugh
Medical Biophysics, University of Toronto, Toronto, Canada
Competing interests
No competing interests declared.
Marcus O Butler
Princess Margaret Cancer Centre, University Health Network, Toronto, Canada
Competing interests
Marcus O Butler, Marcus O. Butler has served on advisory boards for Merck, BMS, Novartis, GSK, Immunocore, immunovaccine, Sanofi, and EMD Serono and received research funding for investigator initiated clinical trials from Merck and Takara Bio..
Tak W Mak
Princess Margaret Cancer Centre, University Health Network, Toronto, Canada
Competing interests
No competing interests declared.
Pamela S Ohashi
Princess Margaret Cancer Centre, University Health Network, Toronto, Canada
Competing interests
No competing interests declared.
Naoto Hirano
Princess Margaret Cancer Centre, University Health Network, Toronto, Canada
Competing interests
Naoto Hirano, Naoto Hirano reports receiving a research grant from and is a consultant for Takara Bio and Otsuka Pharmaceutical and serving on an advisory board for F. Hoffmann-La Roche. The University Health Network has filed patent application related to this study on which Naoto Hirano is named as an inventor (US16/095,913, US62/813,639, US62/813,642, US62/813,644, US62/813,645, US62/813,647, US62/813,650, US62/813,651, and US62/823,487)..
Ontario Institute for Cancer Research (Clinical Investigator Award,IA-039)
Natural Sciences and Engineering Research Council of Canada (Postgraduate Scholarship)
Terry Fox Research Institute (Immunotherapy NeTwork (iTNT) Program)
Terry Fox Research Institute (Immunotherapy NeTwork (iTNT) Program)
Princess Margaret Cancer Centre Innovattion Accelerator Fund
Princess Margaret Cancer Foundation
Princess Margaret Cancer Foundation
Japan Society for the Promotion of Science (Postdoctoral Fellowship for Overseas Researchers and a Guglietti Fellowship)
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Human subjects: This study was conducted in accordance with the Helsinki Declaration and approved by the Research Ethics Board of the University Health Network, Toronto, Canada (UHN REB# 11-0343, 11-0348). Written informed consent was obtained from all healthy donors who provided peripheral blood samples.
© 2020, Murata et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.